Women accuse Carefree liner makers of exposing users to cancer-linked chemical

Hundreds of women accuse the manufacturers of Carefree panty liners of exposing them to a potentially cancer-causing chemical, according to a lawsuit described by ibtimes.co.uk. The plaintiffs allege that they developed serious illnesses after years of using the products.

Those allegations have not been proven in court, and the lawsuit does not establish that the liners caused the illnesses. The complaint, as summarized by ibtimes.co.uk, alleges that the plaintiffs regularly wore the liners for extended periods, sometimes more than 10 hours. It claims that this use meant prolonged contact with sensitive genital tissue.

These are allegations by the plaintiffs, not established findings about product contents or health effects. The New York Post separately reports that the suit alleges Carefree liners contained PFOA. The outlet’s account identifies the chemical in its excerpt, while ibtimes.co.uk describes the case more generally as involving an allegedly cancer-causing chemical.

The New York Post also reports that the lawsuit says the chemicals can remain in the body for years and have been linked to serious health conditions, including cancer. The claims do not establish that PFOA was present in the liners or that use of the products caused any illness.

The plaintiffs further claim that the companies were notified on 6 February 2024 that PFOA had allegedly been detected in Carefree liners, but continued selling the products. They also allege that sales continued in California after restrictions on intentionally added PFAS in menstrual products took effect on 1 January 2025.

These assertions about notice and sales are claims in the lawsuit; the reported accounts do not establish them as court findings. The case therefore raises distinct questions about what the products contained, what the companies knew, and whether the alleged exposure caused the reported illnesses.

The reporting describes the plaintiffs’ claims but does not provide an adjudicated answer to those questions. The allegation that the companies received notice is not itself proof that the chemical was present or that it caused harm.

The New York Post’s coverage also points readers toward alternatives, reporting that some shoppers are seeking organic products and that LOLA describes its cotton pads as toxin-free and made with hypoallergenic ingredients. That consumer-product framing differs from ibtimes.co.uk’s emphasis on the plaintiffs’ alleged exposure, illnesses, and claims about continued sales.

Neither account establishes that an alternative product prevents illness or that the Carefree allegations are true. The central issue remains the evidence behind the lawsuit: whether PFOA was present in Carefree liners, whether the companies received the alleged notice, and whether any exposure caused the illnesses claimed by plaintiffs.